Fabry Disease

Common Name(s)

Fabry Disease, Anderson-Fabry Disease, Ceramide Trihexosidosis

Fabry disease is an inherited disorder that results from the buildup of a particular type of fat in the body's cells and affects many parts of the body. Signs and symptoms may include episodes of pain, particularly in the hands and feet (acroparesthesias); clusters of small, dark red spots on the skin called angiokeratomas; a decreased ability to sweat (hypohidrosis); cloudiness of the front part of the eye (corneal opacity); and hearing loss. Potentially severe complications can include progressive kidney damage, heart attack, and stroke. Milder forms of the disorder may appear later in life and affect only the heart or kidneys. Fabry disease is caused by mutations in the GLA gene and is inherited in an X-linked manner. Treatment may include enzyme replacement therapy (ERT); pain medications, ACE inhibitors; and chronic hemodialysis or renal transplantation for end stage renal disease.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fabry Disease" for support, advocacy or research.

Logo
Canadian Fabry Association

To undertake public and private education and awareness, dissemination and publication of information about Fabry disease; initiate, encourage and support research and investigation into its causes and treatment, and to provide funds in respect thereof; to promote better understanding, management and treatment; and to arrange for, coordinate and increase the facilities available for diagnosis, consultation and treatment of those suffering from Fabry disease.

Last Updated: 2 Dec 2009

View Details
Fabry International Network

FINs vision is of a world where every person affected by Fabry disease has the best quality of life possible through early diagnosis, treatment and cure. The primary aim of the FIN is to facilitate collaboration between organizations to support those affected by Fabry disease. It seeks to do this primarily through enabling communication, promoting best practice and acting as an independent forum for Fabry patients around the world.

Last Updated: 5 Aug 2013

View Details
Fabry Support & Information Group

It is the mission of the Fabry Support & Information Group to provide the Fabry community and the general public with information, advocacy, education and compassionate support to improve the quality of life and the quality of care for Fabry patients and family members.

Last Updated: 3 Mar 2013

View Details
National Fabry Disease Foundation

The mission of the National Fabry Disease Foundation is to help ensure that all individuals with Fabry disease are identified, diagnosed and treated in time to avoid a diminished quality of life or life threatening consequences, to provide assistance to individuals with Fabry disease and their families, to provide Fabry disease education and awareness, to promote continued research and data-gathering to improve treatment opportunities and to find a cure.

Last Updated: 24 Nov 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fabry Disease" for support, advocacy or research.

Logo
Canadian Fabry Association

To undertake public and private education and awareness, dissemination and publication of information about Fabry disease; initiate, encourage and support research and investigation into its causes and treatment, and to provide funds in respect thereof; to promote better understanding, management and treatment; and to arrange for, coordinate and increase the facilities available for diagnosis, consultation and treatment of those suffering from Fabry disease.

http://www.fabrycanada.com

Last Updated: 2 Dec 2009

View Details
Fabry International Network

FINs vision is of a world where every person affected by Fabry disease has the best quality of life possible through early diagnosis, treatment and cure. The primary aim of the FIN is to facilitate collaboration between organizations to support those affected by Fabry disease. It seeks to do this primarily through enabling communication, promoting best practice and acting as an independent forum for Fabry patients around the world.

http://www.fabrynetwork.org/

Last Updated: 5 Aug 2013

View Details
Fabry Support & Information Group

It is the mission of the Fabry Support & Information Group to provide the Fabry community and the general public with information, advocacy, education and compassionate support to improve the quality of life and the quality of care for Fabry patients and family members.

http://www.Fabry.org

Last Updated: 3 Mar 2013

View Details
National Fabry Disease Foundation

The mission of the National Fabry Disease Foundation is to help ensure that all individuals with Fabry disease are identified, diagnosed and treated in time to avoid a diminished quality of life or life threatening consequences, to provide assistance to individuals with Fabry disease and their families, to provide Fabry disease education and awareness, to promote continued research and data-gathering to improve treatment opportunities and to find a cure.

http://www.fabrydisease.org

Last Updated: 24 Nov 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Fabry Disease" returned 274 free, full-text research articles on human participants. First 3 results:

A thermodynamic assay to test pharmacological chaperones for Fabry disease.
 

Author(s): Giuseppina Andreotti, Valentina Citro, Antonella Correra, Maria Vittoria Cubellis

Journal: Biochim. Biophys. Acta. 2014 Mar;1840(3):1214-24.

 

The majority of the disease-causing mutations affect protein stability, but not functional sites and are amenable, in principle, to be treated with pharmacological chaperones. These drugs enhance the thermodynamic stability of their targets. Fabry disease, a disorder caused by mutations ...

Last Updated: 22 Jan 2014

Go To URL
Successful desensitization with agalsidase alfa in 2 brothers with Fabry disease.
 

Author(s): O Aydin, C S Kasapkara, G E Celik

Journal: J Investig Allergol Clin Immunol. 2013 ;23(5):367-8.

 

Last Updated: 22 Nov 2013

Go To URL
[Guidelines for diagnosis, monitoring and treatment of Fabry disease].
 

Author(s): , Pablo Neumann, Norberto Antongiovanni, Alejandro Fainboim, Isaac Kisinovsky, Hernán Amartino, Gustavo Cabrera, Sergio Carmona, Romina Ceci, Alberto Cicerán, Martín Choua, Griselda Doxastakis, Sonia De Maio, Roberto Ebner, Ana María Escobar, Gustavo Ferrari, Mariano Forrester, Norberto Guelbert, Paula Luna, Cinthia Marchesoni, Francisca Masllorens, Juan Politei, Ricardo Reisin, Diego Ripeau, Paula Rozenfeld, Graciela Serebrinsky, Ana Lía Tarabuso, Juan Trípoli

Journal: Medicina (B Aires). 2013 ;73(5):482-94.

 

Fabry disease is an X-linked hereditary lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A. Knowledge about this disease, and its medical management, has made remarkable progress in the last decade, including the development of its specific treatment. ...

Last Updated: 24 Oct 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Fabry Disease" returned 35 free, full-text review articles on human participants. First 3 results:

Fibrosis: a key feature of Fabry disease with potential therapeutic implications.
 

Author(s): Frank Weidemann, Maria D Sanchez-Niño, Juan Politei, João-Paulo Oliveira, Christoph Wanner, David G Warnock, Alberto Ortiz

Journal:

 

Fabry disease is a rare X-linked hereditary disease caused by mutations in the AGAL gene encoding the lysosomal enzyme alpha-galactosidase A. Enzyme replacement therapy (ERT) is the current cornerstone of Fabry disease management. Involvement of kidney, heart and the central nervous ...

Last Updated: 9 Aug 2013

Go To URL
Renal complications of Fabry disease in children.
 

Author(s): Behzad Najafian, Michael Mauer, Robert J Hopkin, Einar Svarstad

Journal: Pediatr. Nephrol.. 2013 May;28(5):679-87.

 

Fabry disease is an X-linked α-galactosidase A deficiency, resulting in accumulation of glycosphingolipids, especially globotriaosylceramide, in cells in different organs in the body. Renal failure is a serious complication of this disease. Fabry nephropathy lesions are present and ...

Last Updated: 21 Mar 2013

Go To URL
Anderson-Fabry disease: a cardiomyopathy that can be cured.
 

Author(s): Aris Anastasakis, Elias Sevdalis, Efstathios Papatheodorou, Christodoulos Stefanadis

Journal: Hellenic J Cardiol. ;52(4):316-26.

 

Last Updated: 21 Sep 2011

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
 

Status: Recruiting

Condition Summary: Fabry Disease; Fabry´s Disease; Anderson-Fabry Disease

 

Last Updated: 3 Jun 2014

Go to URL
Fabry Disease Registry
 

Status: Recruiting

Condition Summary: Fabry Disease

 

Last Updated: 26 Aug 2014

Go to URL
Androgenetic Alopecia in Fabry Disease
 

Status: Recruiting

Condition Summary: Fabry Disease

 

Last Updated: 21 Mar 2014

Go to URL